Docket Management
Docket: 00N-1364 - Prescription Drug User Fee Act (PDUFA)
Comment Number: EC -14

Accepted - Volume 1

Comment Record
Commentor Miss Sarah Kunkleman Date/Time 2000-08-15 20:02:48
Organization NARAL
Category Individual

Comments for FDA General
Questions
1. General Comments ECP's are a means of protecting a woman's and her family's health and well-being, for this reason I strongly urge the FDA to weight the options of making ECP's available in an over the counter form. ECP's have been found to be safe, effective means of preventing unintended pregnancies. The availability of ECP's can reduce the number of adverse effects associated with unintended pregnancies. Research has shown that women do not abuse ECP's when they have a supply readily available- the women studied continued using birth control methods. Accidents and birth control methods do fail and this is a very private to women and their partners. Over the counter ECP's would give women the option of protecting themselves immediately without having to wait for a doctor's appointment. For many lower income families, many who do not have easy access to medical care, this is an exceptionally strong point.




EC -14